Avoro Capital Advisors LLC Acadia Pharmaceuticals Inc Transaction History

Avoro Capital Advisors LLC

$6.65 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $29.6 Million - $61.9 Million	-2,275,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.57 Million - $2.06 Million	75,000 Added 3.41%	2,275,000 $55.1 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $3.81 Million - $5.99 Million	-241,658 Reduced 9.9%	2,200,000 $36.5 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $1.13 Million - $1.6 Million	-58,342 Reduced 2.33%	2,441,658 $59.6 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $13.8 Million - $30.2 Million	550,000 Added 28.21%	2,500,000 $64.5 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $80 Million - $111 Million	1,950,000 New	1,950,000 $104 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $5.69 Million - $7.65 Million	-145,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $4.59 Million - $6.8 Million	145,000 New	145,000 $6.13 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $32.1 Million - $45.6 Million	-887,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $9.72 Million - $19.3 Million	-437,500 Reduced 33.02%	887,500 $31.9 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $21.4 Million - $36.3 Million	1,325,000 New	1,325,000 $35.6 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $1.43 Million - $2.29 Million	-100,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $1.3 Million - $2.18 Million	100,000 New	100,000 $2.08 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $4.78 Million - $7.08 Million	-317,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $7.13 Million - $10.3 Million	317,100 New	317,100 $7.13 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account